Development of quinic acid-conjugated nanoparticles as a drug carrier to solid tumors

Biomacromolecules. 2013 Jul 8;14(7):2389-95. doi: 10.1021/bm400512g. Epub 2013 Jun 5.


Nanometer-sized drug carriers including polymeric nanoparticles (NPs) have been used to increase biodistribution of a drug in tumors, thereby reducing the effective dose of chemotherapy. NPs increase drug delivery to tumors to a certain extent, but the amount reaching tumors is only a small fraction of the total administered NPs because they depend on passive accumulation via the leaky vasculature surrounding tumors. In an attempt to further increase the drug delivery to tumors, we develop a polymeric NP system that interacts with an endothelial tumor marker. The NPs are decorated with quinic acid, a synthetic mimic of sialyl Lewis-x, which binds to E-selectin, overexpressed on the surface of endothelial cells surrounding solid tumors. The NPs selectively bind to endothelial cells activated with tumor necrosis factor-α, with weak affinity at a relatively high shear stress. These properties may help NPs reach tumors by increasing the encounter of NPs with the peritumoral endothelium without hindering subsequent transport of the NPs.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, Non-P.H.S.

MeSH terms

  • Antineoplastic Agents / administration & dosage*
  • Antineoplastic Agents / chemistry*
  • Cell Line, Tumor
  • Drug Carriers / chemistry*
  • E-Selectin / chemistry
  • HL-60 Cells
  • Human Umbilical Vein Endothelial Cells / chemistry
  • Humans
  • Nanoparticles / chemistry*
  • Neoplasms / drug therapy*
  • Quinic Acid / chemistry*


  • Antineoplastic Agents
  • Drug Carriers
  • E-Selectin
  • Quinic Acid